Porton Pharma (Jiangxi) Co., Ltd. has established and implemented a complete quality system which was based on Chinese 2010 GMP and refers to the cGMP regulations of the current version of THE US FDA 21 CFR Part 210/211, EU cGMP, ICH, ISO, etc. and other domestic and foreign regulations，to provide products that meet the quality attributes of customers and market demand, and adopt the strategy of continuous improvement, and constantly improve the quality management level of Jiangxi Porton..
“Safety and reliability, stable quality; customer satisfaction, pharmaceutical administration rest assured; continuous improvement, striving for first-class ". Ensure cGMP compliance and meet customers’ quality expectation.
Boten is committed to implementing quality management into the whole life cycle of product R & D, production, control and release. Guided by customer needs, it continues to provide a full range of products and services from starting materials to finished drugs, continuously improves, meets and exceeds customer expectations, and establishes a global leading pharmaceutical service platform to make new drugs benefit more patients faster.
Porton abides by the quality commitment of "system compliance, continuous improvement, customer orientation" and continuously improves the quality management system.
Quality audit and certificate:
2017In February 2017, the company passed the ISO9001 quality management system certification and obtained the certificate
Passed the quality audit of Novartis, Pfizer, Boehringer Ingelheim, TEVA, Aurobindo, Mylan, etc.
We have more than 80 kinds of testing instruments, including HPLC, GC, IR, KF and so on, which can meet the testing requirements of products and different raw materials.